Iodine-125 orbital brachytherapy with a prosthetic implant in situ

Strahlentherapie und Onkologie

Volumn 187, Issue 5, 2011, Pages 322-327

  Stannard, Clare ^a   Maree, Gert ^a   Munro, Roger ^a   Lecuona, Karin ^a   Sauerwein, Wolfgang ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Brachytherapy; Iodine 125; Orbital radiotherapy; Retinoblastoma; Uveal melanoma

Indexed keywords

IODINE 125;

ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CHILD; CLINICAL ARTICLE; ENDOPROSTHESIS; ENUCLEATION; EYE CANCER; FEMALE; HUMAN; MALE; MELANOMA; ORBIT; RADIATION DOSE; RETINOBLASTOMA; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 79960303988     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-2177-y     Document Type: Article

References (22)

1. Abramson DH, Frank CM. Second non-ocular malignancies in survivors of bilateral retinoblastoma: A possible age effect on radiation related risk. Ophthalmology 1998;105:573-80. (Pubitemid 28180204)
2. Chantada G, Doz F, Antoneli CBG et al. A proposal for an International Retinoblastoma Staging System. Pediatr Blood Cancer 2006;47:801-5. (Pubitemid 44476757)
3. Christmas NJ, Van Quill K, Murray TG et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 2000;118:503-6. (Pubitemid 30203145)
4. Damato B. Ocular tumours: diagnosis and treatment. Ch. 7. Uveal Melanoma. 1st Edition Oxford: Butterworth Heinmann. 2000, p. 87.
5. Davidson A, Desai F, Stannard C et al. Intraocular rhabdomyosarcoma in the sibling of a patient with a cerebellar medulloepithelioma. J Pediatr Hematol Oncol 2006;28:476-8. (Pubitemid 44114559)
6. De Potter P, Shields CL, Shields JA et al. Use of the hydroxyapatite ocular implant in the pediatric population. Arch Ophthalmol 1994;112:208-12. (Pubitemid 24058402)
7. De Sutter E, Havers W, Hopping W et al. The prognosis of retinoblastoma in terms of survival. A computer assisted study. Part II. Ophthalmic Paediatr Genet 1987;8:85-8. (Pubitemid 17116751)
8. Doline S, Needleman HL, Petersen RA et al. The effect of radiotherapy in the treatment of retinoblastoma upon developing dentition. J Pediatr Ophthalmol Strabismus 1980;17:109-13. (Pubitemid 10068336)
9. Fountain TR, Goldberger S, Murphree AL. Orbital development after enucleation in early childhood. Ophthal Plast Reconstr Surg 1999;15:32-6. (Pubitemid 29164522)
10. Imhoff SM, Mouritz MP, Hofman P. Quantification of orbital and midfacial growth retardation after megavoltage irradiation in children with retinoblastoma. Ophthalmology 1996;103:263-8.
11. Khelfaoui F, Validire P, Auperin A et al. Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution. Cancer 1996;77:1206-13. (Pubitemid 26080915)
12. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 1987;94:371-7. (Pubitemid 17056025)
13. Pomarede R, Czernichow P, Zucker JM et al. Incidence of anterior pituitary deficiency after radiotherapy at an early age: study in retinoblastoma. Acta Paediatr Scand 1984:73:115-9. (Pubitemid 14177215)
14. Rubin CM, Robison LL, Cameron D et al. Intraocular retinoblastoma Group V: an analysis of prognostic factors. J Clin Onc 1985;3:680-5. (Pubitemid 15119241)
15. Sauerwein W, Wittig A, Westekemper H, et al. Tumours of the conjunctiva-A challenge for radiation therapy. Strahlenther Onkol 2009;185 (Sondernr 1): 76 (abstr P25).
16. Scalliet P, Wambersie A. Which RBE for iodine-125 in clinical applications. Radiother Oncol 1987;9:221-30. (Pubitemid 17144982)
17. Sealy R, Stannard C, Shackleton D. Improved cosmesis in retinoblastoma patients treated with iodine-125 orbital irradiation. Ophthalmic Paediatr Genet 1987;8:95-9. (Pubitemid 17116753)
18. Shields JA. Misconceptions and techniques in the management of retinoblastoma. The 1992 Paul Henkind Memorial Lecture. Retina 1992;12:320-30.
19. Singh AD, Shields CL, Shields JA. Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus 2000;37:134-41. (Pubitemid 30350253)
20. Stannard C, Lipper S, Sealy R et al. Retinoblastoma: correlation of invasion of the optic nerve and choroid with prognosis and metastases. Br J Ophthalmol 1979;63:560-70. (Pubitemid 9211220)
21. 125I brachytherapy. Int J Radiat Oncol Biol Phys 2002;54:1446-54. (Pubitemid 35380046)
22. Strege RJ, Kovács G, Meyer JE et al. Perioperative intensity-modulated brachy therapy for refractory orbital rhabdomyosarcomas in children. Strahlenther Onkol 2009;185:789-98.